Calendar

Week of Apr 20, 2026

Apr 25, 2026phase 1 completion73d agoShenzhen Salubris Pharmaceuticals Co Ltd — (alisartan calcium + amlodipine besylate + sacubitril) (Phase I Trial Completion)(alisartan calcium + amlodipine besylate + sacubitril)

Therapy area: Cardiovascular. Indication: Hypertension

full page →(alisartan calcium + amlodipine besylate + sacubitril) →source: globaldata

Week of Apr 27, 2026

Apr 28, 2026phase 1 completion70d agoInternational Bio Service Co Ltd — Bisoprolol fumarate (Phase I Trial Completion)BISOPROLOL FUMARATE

Therapy area: Cardiovascular. Indication: Hypertension

full page →BISOPROLOL FUMARATE →source: globaldata

Apr 28, 2026phase 1 completion70d agoPolfa Tarchomin SA — empagliflozin (Phase I Trial Completion)SYNJARDY

Therapy area: Cardiovascular, Metabolic Disorders. Indication: Congestive Heart Failure (Heart Failure), Type 2 Diabetes

full page →SYNJARDY →source: globaldata

Apr 29, 2026phase 1 completion69d agoUniversity of Washington — autologous mitochondria (Phase I Trial Completion)autologous mitochondria

Therapy area: Cardiovascular. Indication: Cerebrovascular Disease, Ischemia

full page →autologous mitochondria →source: globaldata

Apr 30, 2026phase 1 completion68d agoJiangxi Jemincare Group Co Ltd — JMKX-003142 (Phase I Trial Completion)JMKX-003142

Therapy area: Cardiovascular, Genetic Disorders. Indication: Edema, Polycystic Kidney Disease

full page →JMKX-003142 →source: globaldata

Apr 30, 2026phase 1 completion68d agoIlife Consulting Sarl — PST-611 (Phase I Trial Completion)PST-611

Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Dry (Atrophic) Macular Degeneration, Geographic Atrophy

full page →PST-611 →source: globaldata

Apr 30, 2026phase 1 completion68d agoJiangsu Postgraduate Research and Practice Innovation Program — acetaminophen (Phase I Trial Completion)acetaminophen ER

Therapy area: Cardiovascular. Indication: Patent Ductus Arteriosus

full page →acetaminophen ER →source: globaldata

Apr 30, 2026phase 1 completion68d agoPhrae Hospital — bupivacaine (Phase I Trial Completion)bupivacaine

Therapy area: Cardiovascular, Central Nervous System, Gastrointestinal. Indication: Hypotension, Post Operative Nausea And Vomiting, Post-Operative Pain

full page →bupivacaine →source: globaldata

Apr 30, 2026phase 1 completion68d agoBarts Charity — undisclosed Covid-19 vaccine (Phase I Trial Completion)undisclosed Covid-19 vaccine

Therapy area: Cardiovascular. Indication: Cardiovascular Disease, Endothelial Dysfunction

full page →undisclosed Covid-19 vaccine →source: globaldata

Week of Apr 20, 2026

Week of Apr 27, 2026